|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,847 |
52
Week Range: |
$0.0001 - $0.058 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Connors James J Ii |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$126,250 |
I/I |
46,656 |
17,667,212 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$116,448 |
I/I |
43,034 |
16,296,007 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$126,250 |
I/I |
46,656 |
17,667,212 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$150,990 |
D/D |
55,799 |
21,129,278 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$126,250 |
I/I |
46,656 |
17,667,212 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-10 |
4 |
OE |
$2.42 |
$98,029 |
I/I |
35,376 |
16,339,042 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-10 |
4 |
OE |
$2.42 |
$106,274 |
I/I |
38,351 |
17,713,868 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-10 |
4 |
OE |
$2.42 |
$127,101 |
D/D |
45,867 |
21,185,077 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-09 |
4 |
OE |
$2.42 |
$97,388 |
I/I |
36,657 |
16,374,417 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-09 |
4 |
OE |
$2.42 |
$105,590 |
I/I |
39,744 |
17,752,219 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-09 |
4 |
OE |
$2.42 |
$126,275 |
D/D |
47,530 |
21,230,944 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-08 |
4 |
OE |
$2.42 |
$192,584 |
I/I |
69,277 |
16,411,074 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-08 |
4 |
OE |
$2.42 |
$208,786 |
I/I |
75,105 |
17,791,962 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-08 |
4 |
OE |
$2.42 |
$249,698 |
D/D |
89,822 |
21,278,474 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$71,715 |
I/I |
26,193 |
16,480,350 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$77,747 |
I/I |
28,396 |
17,867,066 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$71,715 |
I/I |
26,193 |
16,480,350 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$77,747 |
I/I |
28,396 |
17,867,066 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$92,981 |
D/D |
33,960 |
21,368,296 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-11-07 |
4 |
OE |
$2.42 |
$77,747 |
I/I |
28,396 |
17,867,066 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-04 |
4 |
OE |
$2.42 |
$41,142 |
I/I |
16,566 |
16,506,542 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-04 |
4 |
OE |
$2.42 |
$44,599 |
I/I |
17,958 |
17,895,462 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-04 |
4 |
OE |
$2.42 |
$53,414 |
D/D |
21,508 |
21,402,256 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-03 |
4 |
OE |
$2.42 |
$97,264 |
I/I |
37,212 |
16,523,107 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-03 |
4 |
OE |
$2.42 |
$105,445 |
I/I |
40,342 |
17,913,421 |
|
- |
|
825 Records found
|
|
Page 23 of 33 |
|
|